Results 61 to 70 of about 3,193,785 (231)

Does the COVID‐19 Pandemic Affect the Pattern of Lower Urinary Tract Symptoms?

International Journal of Urological Nursing, Volume 19, Issue 2, July 2025.
ABSTRACT To determine whether Lower Urinary Tract Symptoms (LUTS) and infections appeared or worsened after COVID‐19, particularly in those with pre‐existing LUTS. This research will be the first of its kind in Jordan as we seek to shed light on the potential impact of COVID‐19 on the urinary system.
Saleh Abuorouq, Zainab A. Bani‐Issa, Aysheh Ali Al Shurman, Saba Alsmadi, Yara Q. Aljarrah, Mu'taz Hanandeh, Ruba M. Aljarrah, Hamzeh Monawer, Dania Darwish, Sojoud Amarat, Mohammad Al‐Zubi, Hashem Abu Serhan   +11 more
wiley   +1 more source

A Delphi Consensus Document on the Use of Single-Inhaler Fixed-Dose Triple Therapies in COPD Patients

International Journal of COPD, 2020
José Luis López-Campos,1,2 Bernardino Alcázar Navarrete,3 Juan Antonio Riesco Miranda,2,4 Borja G Cosío,2,5 Juan P de-Torres,6 Bartolomé Celli,7 Carlos A Jiménez-Ruiz,8 Ciro Casanova Macario9 1Unidad Mé ...
López-Campos JL, Alcázar Navarrete B, Riesco Miranda JA, Cosío BG, de-Torres JP, Celli B, Jiménez-Ruiz CA, Casanova Macario C   +7 more
doaj  

Identifying Barriers and Enablers for Nurse‐Initiated Care for Designing Implementation at Scale in Australian Emergency Departments: A Mixed Methods Study

Journal of Clinical Nursing, Volume 34, Issue 7, Page 2718-2736, July 2025.
ABSTRACT Aim The aim of this study was to (i) identify barriers and enablers and (ii) inform mitigating or strengthening strategies for implementing nurse‐initiated care protocols at scale in emergency departments (EDs). Design Embedded mixed methods. Methods The study included four clusters with a total 29 EDs in NSW, Australia.
Sarah Kourouche, Julie Considine, Ling Li, Margaret Murphy, Ramon Z. Shaban, Mary K. Lam, Saartje Berendsen Russell, Margaret Fry, Christina Aggar, Michael M. Dinh, Amith Shetty, Timothy Shaw, Radhika V. Seimon, Nanda R. Aryal, James A. Hughes, Wayne Varndell, Kate Curtis   +16 more
wiley   +1 more source

Inhaler Devices for Delivery of LABA/LAMA Fixed-Dose Combinations in Patients with COPD

Pulmonary Therapy, 2019
Inhaled fixed-dose combinations (FDCs) of a long-acting β-agonist (LABA) and a long-acting muscarinic antagonist (LAMA) have become the cornerstone for the maintenance treatment of symptomatic COPD patients.
Anthony D’Urzo, Kenneth R. Chapman, James F. Donohue, Peter Kardos, M. Reza Maleki-Yazdi, David Price   +5 more
doaj   +1 more source

Contemporary Concise Review 2024: Chronic Obstructive Pulmonary Disease

Respirology, Volume 30, Issue 7, Page 574-586, July 2025.
SUMMARY OF KEY POINTS Non‐smoking COPD is common in LMICs, especially in women. Biomass fuel and air pollution are major risk factors with distinct pathophysiology. The ‘eosinophilic’ endotype in COPD is biologically distinct from asthma. PRISm, FEV1/FVC Z‐scores, and quantitative CT improve early COPD detection.
Sarita Thawanaphong, Parameswaran Nair
wiley   +1 more source

Role of combined indacaterol and glycopyrronium bromide (QVA149) for the treatment of COPD in Japan

International Journal of COPD, 2015
Nobuyuki Horita, Takeshi Kaneko Department of Pulmonology, Yokohama City University Graduate School of Medicine, Yokohama, Japan Abstract: Once-daily dual-bronchodilator therapy with combined indacaterol and glycopyrronium bromide in one device ...
Horita N, Kaneko T
doaj  

Current and potential improvements in the treatment of asthma from increased understanding of airway pathophysiology

Allergology International, 2002
The mainstay of chronic asthma management consists of using pharmacological agents that induce bronchodilatation, such as short-acting β-adrenergic receptor agonists (bronchodilators or relievers), and that control the chronic inflammatory process, such ...
Kian Fan Chung
doaj   +1 more source

Are there specific clinical characteristics associated with physician’s treatment choices in COPD?

Respiratory Research, 2019
Background The number of pharmacological agents and guidelines available for COPD has increased markedly but guidelines remain poorly followed. Understanding underlying clinical reasoning is challenging and could be informed by clinical characteristics ...
Nicolas Roche, Anestis Antoniadis, David Hess, Pei Zhi Li, Eric Kelkel, Sylvie Leroy, Christophe Pison, Pierre-Régis Burgel, Bernard Aguilaniu, COLIBRI COPD Research Group   +9 more
doaj   +1 more source

Evaluating bronchodilator response in pediatric patients with post-infectious bronchiolitis obliterans: use of different criteria for identifying airway reversibility

Jornal Brasileiro de Pneumologia
Objective: Post-infectious bronchiolitis obliterans (PIBO) is a clinical entity that has been classified as constrictive, fixed obstruction of the lumen by fibrotic tissue.
Rita Mattiello, Paula Cristina Vidal, Edgar Enrique Sarria, Paulo Márcio Pitrez, Renato Tetelbom Stein, Helena Teresinha Mocelin, Gilberto Bueno Fischer, Marcus Herbert Jones, Leonardo Araújo Pinto   +8 more
doaj   +1 more source

Equivalência farmacêutica da formulação combinada de budesonida e formoterol em cápsula única com dispositivo inalador de pó Pharmaceutical equivalence of the combination formulation of budesonide and formoterol in a single capsule with a dry powder inhaler

Jornal Brasileiro de Pneumologia, 2012
OBJETIVO: Avaliar a equivalência farmacêutica da formulação teste (associação fixa de budesonida e fumarato de formoterol em cápsula única dispensada com o dispositivo Aerocaps®) em relação a uma formulação referência (budesonida e fumarato de formoterol
Marina Andrade-Lima, Luiz Fernando Ferreira Pereira, Ana Luisa Godoy Fernandes   +2 more
doaj   +1 more source